Role of human mast cells and basophils in bronchial asthma

Advances in Immunology

Volumn 88, Issue , 2005, Pages 97-160

  Marone, Gianni ^a   Triggiani, Massimo ^a   Genovese, Arturo ^a   De Paulis, Amato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; GLUCOCORTICOID; MONOCLONAL ANTIBODY; TACROLIMUS; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ASTHMA; BASOPHIL; CELL ACTIVATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MOLECULAR MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ADENYLATE CYCLASE; ANTIGENS, DIFFERENTIATION; ASTHMA; BASOPHILS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKININS; EICOSANOIDS; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; PROSTAGLANDIN D2; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 26444463924     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(05)88004-6     Document Type: Review

References (365)

1. 2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells J. Immunol. 172 2004 1227 1236
2. Abraham S.N., and Malaviya R. Mast cell-enterobacteria interactions during infection G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 381 396
3. Akin C., Brockow K., D' Ambrosio C., Kirshenbaum A.S., Ma Y., Longley B.J., and Metcalfe D.D. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit Exp. Hematol. 31 2003 686 692
4. Altman L.C., Munk Z., Seltzer J., Noonan N., Shingo S., Zhang J., and Reiss T.F. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group J. Allergy Clin. Immunol. 102 1998 50 56
5. Amin K., Ludviksdottir D., Janson C., Nettelbladt O., Bjornsson E., Roomans G.M., Boman G., Seveus L., and Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group Am. J. Respir. Crit. Care Med. 162 2000 2295 2301
6. Andrade M.V., Hiragun T., and Beaven M.A. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells J. Immunol. 172 2004 7254 7262
7. Arm J.P. Generation of cytokines through the leukocyte immunoglobulin-like receptors G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 162 166
8. Artuc M., Steckelings U.M., and Henz B.M. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors J. Invest. Dermatol. 118 2002 391 395
9. Asai K., Kitaura J., Kawakami Y., Yamagata N., Tsai M., Carbone D.P., Liu F.T., Galli S.J., and Kawakami T. Regulation of mast cell survival by IgE Immunity 14 2001 791 800
10. Atasoy U., Curry S.L., Lopez de Silanes I., Shyu A.B., Casolaro V., Gorospe M., and Stellato C. Regulation of eotaxin gene expression by TNF-α and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR J. Immunol. 171 2003 4369 4378
11. Axcrona K., Bjorck L., and Leanderson T. Multiple ligand interactions for bacterial immunoglobulin-binding proteins on human and murine cells of the hematopoetic lineage Scand. J. Immunol. 42 1995 359 367
12. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 347 2002 911 920
13. Baghestanian M., Hofbauer R., Kiener H.P., Bankl H.C., Wimazal F., Willheim M., Scheiner O., Fureder W., Muller M.R., Bevec D., Lechner K., and Valent P. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells Blood 90 1997 4438 4449
14. Barnes N., Thomas M., Price D., and Tate H. The national montelukast survey J. Allergy Clin Immunol 115 2005 47 54
15. Bastan R., Peirce M.J., and Peachell P.T. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung Eur. J. Pharmacol. 430 2001 135 141
16. Baud L., Perez J., Denis M., and Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin J. Immunol. 138 1987 1190 1195
17. Beaulieu S., Robbiani D.F., Du X., Rodrigues E., Ignatius R., Wei Y., Ponath P., Young J.W., Pope M., Steinman R.M., and Mojsov S. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells J. Immunol. 169 2002 2925 2936
18. H3 gene products: natural ligands for HIV gp120 Science 261 1993 1588 1591
19. Bischoff S.C., and Dahinden C.A. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils Blood 79 1992 2662 2669
20. Bischoff S.C., de Weck A.L., and Dahinden C.A. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a Proc. Natl. Acad. Sci. USA 87 1990 6813 6817
21. Bischoff S.C., Krieger M., Brunner T., and Dahinden C.A. Monocyte chemotactic protein 1 is a potent activator of human basophils J. Exp. Med. 175 1992 1271 1275
22. Björck L. Protein L. A novel bacterial cell wall protein with affinity for Ig L chains J. Immunol. 140 1988 1194 1197
23. Blank U., and Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis Trends Immunol. 25 2004 266 273
24. Boesiger J., Tsai M., Maurer M., Yamaguchi M., Brown L.F., Claffey K.P., Dvorak H.F., and Galli S.J. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression J. Exp. Med. 188 1998 1135 1145
25. Boulet L.P., Laviolette M., Turcotte H., Cartier A., Dugas M., Malo J.L., and Boutet M. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine Chest 112 1997 45 52
26. Boumiza R., Monneret G., Forissier M.F., Savoye J., Gutowski M.C., Powell W.S., and Bienvenu J. Marked improvement of the basophil activation test by detecting CD203c instead of CD63 Clin. Exp. Allergy 33 2003 259 265
27. Bouvet J.P., Pires R., Lunel-Fabiani F., Crescenzo-Chaigne B., Maillard P., Valla D., Opolon P., and Pillot J. Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis J. Immunol. 145 1990 1176 1180
28. Bouvet J.P., Pires R., Charlemagne J., Pillot J., and Iscaki S. Non-immune binding of human protein Fv to immunoglobulins from various mammalian and non-mammalian species Scand. J. Immunol. 34 1991 491 496
29. H-binding specificity of human protein Fv Scand. J. Immunol. 33 1991 381 386
30. Boyce J.A., Mellor E.A., Perkins B., Lim Y.C., and Luscinskas F.W. Human mast cell progenitors use α4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions Blood 99 2002 2890 2896
31. Bressler R.B., Lesko J., Jones M.L., Wasserman M., Dickason R.R., Huston M.M., Cook S.W., and Huston D.P. Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation J. Allergy Clin. Immunol. 99 1997 508 514
32. Brewster C.E., Howarth P.H., Djukanovic R., Wilson J., Holgate S.T., and Roche W.R. Myofibroblasts and subepithelial fibrosis in bronchial asthma Am. J. Respir. Cell Mol. Biol. 3 1990 507 511
33. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma N. Engl. J. Med. 346 2002 1699 1705
34. Brightling C.E., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D., and Bradding P. Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma Clin. Exp. Allergy 33 2003 1711 1716
35. Brown J.K., Jones C.A., Rooney L.A., Caughey G.H., and Hall I.P. Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions Am. J. Physiol. Lung Cell. Mol. Physiol. 282 2002 L197 L206
36. Brunner T., de Weck A.L., and Dahinden C.A. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5 J. Immunol. 147 1991 237 242
37. Brunner T., Heusser C.H., and Dahinden C.A. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation J. Exp. Med. 177 1993 605 611
38. Burd P.R., Thompson W.C., Max E.E., and Mills F.C. Activated mast cells produce interleukin 13 J. Exp. Med. 181 1995 1373 1380
39. Burgi B., Otten U.H., Ochensberger B., Rihs S., Heese K., Ehrhard P.B., Ibanez C.F., and Dahinden C.A. Basophil priming by neurotrophic factors. Activation through the trk receptor J. Immunol. 157 1996 5582 5588
40. Cairns J.A., and Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts J. Clin. Invest. 99 1997 1313 1321
41. Calhoun W.J., Swenson C.A., Dick E.C., Schwartz L.B., Lemanske R.F. Jr., and Busse W.W. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects Am. Rev. Respir. Dis. 144 1991 1267 1273
42. Carmeliet P. Angiogenesis in health and disease Nat. Med. 9 2003 653 660
43. Carroll N.G., Mutavdzic S., and James A.L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects Eur. Respir. J. 19 2002 879 885
44. Casale T.B., Wood D., Richerson H.B., Zehr B., Zavala D., and Hunninghake G.W. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction J. Clin. Invest. 80 1987 1507 1511
45. Casolaro V., Galeone D., Giacummo A., Sanduzzi A., Melillo G., and Marone G. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics Am. Rev. Respir. Dis. 139 1989 1375 1382
46. Casolaro V., Spadaro G., and Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma Am. Rev. Respir. Dis. 142 1990 1108 1111
47. Casolaro V., Spadaro G., Patella V., and Marone G. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils J. Immunol. 151 1993 5563 5573
48. Caughey G.H. Genetic insights into mast cell chymase and tryptase function G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 96 101
49. Chanez P., Lacoste J.Y., Guillot B., Giron J., Barnéon G., Enander I., Godard P., Michel F.B., and Bousquet J. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung Am. Rev. Respir. Dis. 147 1993 1497 1502
50. Chetta A., Zanini A., Foresi A., Del Donno M., Castagnaro A., D' Ippolito R., Baraldo S., Testi R., Saetta M., and Olivieri D. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone Am. J. Respir. Crit. Care Med. 167 2003 751 757
51. Church M.K., and Gradidge C.F. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs Br. J. Pharmacol. 69 1980 663 667
52. Cirillo R., Triggiani M., Siri L., Ciccarelli A., Pettit G.R., Condorelli M., and Marone G. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin J. Immunol. 144 1990 3891 3897
53. Coca A.F., and Cooke R.A. On the classification of the phenomena of hypersensitization J. Immunol. 8 1923 163 182
54. Cohen S.G., and Samter M. "Classics in allergy." 1992 NIH Symposia Foundation Carlsbad (CA)
55. Columbo M., Horowitz E.M., McKenzie-White J., Kagey-Sobotka A., and Lichtenstein L.M. Pharmacologic control of histamine release from human basophils induced by platelet-activating factor Int. Arch. Allergy Immunol. 102 1993 383 390
56. 4 release from human leukocytes J. Allergy Clin. Immunol. 92 1993 325 333
57. Cookson W. Genetics and asthma G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 1998 Academic Press San Diego 13 23
58. Coopman S.A., Johnson R.A., Platt R., and Stern R.S. Cutaneous disease and drug reactions in HIV infection N. Engl. J. Med. 328 1993 1670 1674
59. Corry D.B., Folkesson H.G., Warnock M.L., Erle D.J., Matthay M.A., Wiener-Kronish J.P., and Locksley R.M. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity J. Exp. Med. 183 1996 109 117
60. Dahinden C.A. Differential regulation of basophils functions by chemokines G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 567 577
61. 4 in normal and asthmatic subjects Am. Rev. Respir. Dis. 135 1987 333 337
62. De Falco S., Gigante B., and Persico M.G. Structure and function of placental growth factor Trends Cardiovasc. Med. 12 2002 241 246
63. + cells J. Immunol. 146 1991 2374 2381
64. de Paulis A., Stellato C., Cirillo R., Ciccarelli A., Oriente A., and Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells J. Invest. Dermatol. 99 1992 723 728
65. de Paulis A., Ciccarelli A., de Crescenzo G., Cirillo R., Patella V., and Marone G. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine J. Allergy Clin. Immunol. 98 1996 152 164
66. de Paulis A., Minopoli G., Arbustini E., de Crescenzo G., Dal Piaz F., Pucci P., Russo T., and Marone G. Stem cell factor is localized in, released from, and cleaved by human mast cells J. Immunol. 163 1999 2799 2808
67. + cells J. Immunol. 165 2000 7171 7179
68. de Paulis A., Annunziato F., Di Gioia L., Romagnani S., Carfora M., Beltrame C., Marone G., and Romagnani P. Expression of the chemokine receptor CCR3 on human mast cells Int. Arch. Allergy Immunol. 124 2001 146 150
69. + cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors J. Immunol. 169 2002 4559 4567
70. de Paulis A., Montuori N., Prevete N., Fiorentino I., Rossi F.W., Visconte V., Rossi G., Marone G., and Ragno P. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2 J. Immunol. 173 2004 5739 5748
71. de Paulis A., Prevete N., Fiorentino I., Walls A.F., Curto M., Petraroli A., Castaldo V., Ceppa P., Fiocca R., and Marone G. Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20) J. Immunol. 172 2004 7734 7743
72. Del Prete G., Maggi E., Parronchi P., Chretien I., Tiri A., Macchia D., Ricci M., Banchereau J., De Vries J., and Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants J. Immunol. 140 1988 4193 4198
73. Denburg J.A. Differentiation of human basophils and mast cells G. Marone "Human Basophils and Mast Cells: Biological Aspects" 1995 Karger Basel 49 71
74. Denburg J.A., Richardson M., Telizyn S., and Bienenstock J. Basophil/mast cell precursors in human peripheral blood Blood 61 1983 775 780
75. Desmet C., Gosset P., Pajak B., Cataldo D., Bentires-Alj M., Lekeux P., and Bureau F. Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma J. Immunol. 173 2004 5766 5775
76. Devouassoux G., Metcalfe D.D., and Prussin C. Eotaxin potentiates antigen-dependent basophil IL-4 production J. Immunol. 163 1999 2877 2882
77. Di Nardo A., Vitiello A., and Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide J. Immunol. 170 2003 2274 2278
78. Drazen J.M., Yandava C.N., Dube L., Szczerback N., Hippensteel R., Pillari A., Israel E., Schork N., Silverman E.S., Katz D.A., and Drajesk J. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment Nat. Genet. 22 1999 168 170
79. Dubé J., Chakir J., Laviolette M., Saint Martin S., Boutet M., Desrochers C., Auger F., and Boulet L.P. In vitro procollagen synthesis and proliferative phenotype of bronchial fibroblasts from normal and asthmatic subjects Lab. Invest. 78 1998 297 307
80. Duffy S.M., Lawley W.J., Kaur D., Yang W., and Bradding P. Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation J. Allergy Clin. Immunol. 112 2003 965 972
81. Dunsky E.H., Zweiman B., Fischler E., and Levy D.A. Early effects of corticosteroids on basophils, leukocyte histamine, and tissue histamine J. Allergy Clin. Immunol. 63 1979 426 432
82. Dvorak A.M. Ultrastructural analysis of human mast cells and basophils G. Marone "Human Basophils and Mast Cells: Biological Aspects" 1995 Karger Basel 1 33
83. Dvorak A.M. Ultrastructural features of human basophil and mast cell secretory function G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 63 88
84. Echtenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis Nature 381 1996 75 77
85. Ehrlich P. Beiträge zur kenntniss der granulirten bindegewebszellen und der eosinophilen leukocythen Arch. Anat. Physiol. (Leipzig) 3 1879 166 169
86. Essayan D.M. Cyclic nucleotide phosphodiesterases J. Allergy Clin. Immunol. 108 2001 671 680
87. Eubank T.D., Roberts R., Galloway M., Wang Y., Cohn D.E., and Marsh C.B. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice Immunity 21 2004 831 842
88. Fahy J.V., Fleming H.E., Wong H.H., Liu J.T., Su J.Q., Reimann J., Fick R.B. Jr., and Boushey H.A. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects Am. J. Respir. Crit. Care Med. 155 1997 1828 1834
89. Falcone F.H., Haas H., and Gibbs B.F. The human basophil: A new appreciation of its role in immune responses Blood 96 2000 4028 4038
90. Feistritzer C., Mosheimer B.A., Sturn D.H., Bijuklic K., Patsch J.R., and Wiedermann C.J. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils J. Allergy Clin. Immunol. 114 2004 1077 1084
91. Figueroa D.J., Breyer R.M., Defoe S.K., Kargman S., Daugherty B.L., Waldburger K., Liu Q., Clements M., Zeng Z., O'Neill G.P., Jones T.R., Lynch K.R., Austin C.P., and Evans J.F. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes Am. J. Respir. Crit. Care Med. 163 2001 226 233
92. Flood-Page P., Menzies-Gow A., Phipps S., Ying S., Wangoo A., Ludwig M.S., Barnes N., Robinson D., and Kay A.B. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics J. Clin. Invest. 112 2003 1029 1036
93. Florio G., Petraroli A., Patella V., Triggiani M., and Marone G. The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils AIDS 14 2000 931 938
94. Foster B., Schwartz L.B., Devouassoux G., Metcalfe D.D., and Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils J. Allergy Clin. Immunol. 109 2002 287 293
95. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model J. Exp. Med. 183 1996 195 201
96. Fumo G., Akin C., Metcalfe D.D., and Neckers L. 17-Allylamino-17- demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells Blood 103 2004 1078 1084
97. Füreder W., Agis H., Willheim M., Bankl H.C., Maier U., Kishi K., Muller M.R., Czerwenka K., Radaszkiewicz T., Butterfield J.H., Klappacher G.W., Sperr W.R., Oppermann M., Lechner K., and Valent P. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells J. Immunol. 155 1995 3152 3160
98. Galli S.J., Tsai M., and Wershil B.K. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others Am. J. Pathol. 142 1993 965 974
99. Garbuzenko E., Nagler A., Pickholtz D., Gillery P., Reich R., Maquart F.X., and Levi-Schaffer F. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: A direct role for mast cells in skin fibrosis Clin. Exp. Allergy 32 2002 237 246
100. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., Kishi K., Butterfield J., Dahinden C.A., and Bonnefoi J.Y. Induction of human IgE synthesis in B cells by mast cells and basophils Nature 365 1993 340 343
101. Gauvreau G.M., Lee J.M., Watson R.M., Irani A.M., Schwartz L.B., and O'Byrne P.M. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics Am. J. Respir. Crit. Care Med. 161 2000 1473 1478
102. Geissler E.N., Ryan M.A., and Housman D.E. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene Cell 55 1988 185 192
103. + cells Clin. Exp. Allergy 27 1997 559 567
104. Genovese A., Bouvet J.P., Florio G., Lamparter-Schummert B., Björck L., and Marone G. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E Infect. Immun. 68 2000 5517 5524
105. + cells through interaction with the κ light chains of IgE J. Immunol. 170 2003 1854 1861
106. Gern J.E., and Busse W.W. The role of viral infections in the natural history of asthma J. Allergy Clin. Immunol. 106 2000 201 212
107. Giembycz M.A. Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs 59 2000 193 212
108. Gilchrest H., Cheewatrakoolpong B., Billah M., Egan R.W., Anthes J.C., and Greenfeder S. Human cord blood-derived mast cells synthesize and release I-309 in response to IgE Life Sci. 73 2003 2571 2581
109. Goldstein S.M., Kaempfer C.E., Proud D., Schwartz L.B., Irani A.M., and Wintroub B.U. Detection and partial characterization of a human mast cell carboxypeptidase J. Immunol. 139 1987 2724 2729
110. Gommerman J.L., Oh D.Y., Zhou X., Tedder T.F., Maurer M., Galli S.J., and Carroll M.C. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: A potential mechanism for mast cell activation J. Immunol. 165 2000 6915 6921
111. Graille M., Stura E.A., Corper A.L., Sutton B.J., Taussig M.J., Charbonnier J.B., and Silverman G.J. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity Proc. Natl. Acad. Sci. USA 97 2000 5399 5404
112. Griffin M., Weiss J.W., Leitch A.G., McFadden E.R. Jr., Corey E.J., Austen K.F., and Drazen J.M. Effects of leukotriene D on the airways in asthma N. Engl. J. Med. 308 1983 436 439
113. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D.D., Locksley R.M., and Corry D.B. Requirement for IL-13 independently of IL-4 in experimental asthma Science 282 1998 2261 2263
114. 206 Mol. Biol. Cell 9 1998 875 884
115. Guihard A.I., Pires R., and Bouvet J.P. An endogenous superantigen in the rat gut lumen as a model to study the role of human protein-Fv Scand. J. Immunol. 45 1997 36 42
116. Gupta A.K., and Chow M. Pimecrolimus: A review J. Eur. Acad. Dermatol. Venereol. 17 2003 493 503
117. Hait W.N., Harding M.W., and Handschumacher R.E. Calmodulin, cyclophilin, and cyclosporin A Science 233 1986 987 989
118. Hamilton A., Faiferman I., Stober P., Watson R.M., and O'Byrne P.M. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects J. Allergy Clin. Immunol. 102 1998 177 183
119. 2 in normal and asthmatic men N. Engl. J. Med. 311 1984 209 213
120. Hartnell A., Heinemann A., Conroy D.M., Wait R., Sturm G.J., Caversaccio M., Jose P.J., and Williams T.J. Identification of selective basophil chemoattractants in human nasal polyps as insulin-like growth factor-1 and insulin-like growth factor-2 J. Immunol. 173 2004 6448 6457
121. Heard B.E., Dewar A., Nunn A.J., and Kay A.B. Heterogeneous ultrastructure of human bronchial mast cells: Morphometric subdivision of cell types and evidence for a degranulation gradient Am. J. Respir. Cell Mol. Biol. 3 1990 71 78
122. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R., Williams D.L. Jr., Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N., Liu Y., Austin C.P., George S.R., O'Neill G.P., Metters K.M., Lynch K.R., and Evans J.F. Characterization of the human cysteinyl leukotriene 2 receptor J. Biol. Chem. 275 2000 30531 30536
123. Henderson W.R. Jr., Tang L.O., Chu S.J., Tsao S.M., Chiang G.K., Jones F., Jonas M., Pae C., Wang H., and Chi E.Y. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model Am. J. Respir. Crit. Care Med. 165 2002 108 116
124. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J. Exp. Med. 193 2001 255 261
125. Hiromatsu Y., and Toda S. Mast cells and angiogenesis Microsc. Res. Tech. 60 2003 64 69
126. Hirst S.J., Hallsworth M.P., Peng Q., and Lee T.H. Selective induction of eotaxin release by IL-13 or IL-4 in human airway smooth muscle cells is synergistic with IL-1β and is mediated by the IL-4 receptor α-chain Am. J. Respir. Crit. Care Med. 165 2002 1161 1171
127. Hjertson M., Kivinen P.K., Dimberg L., Nilsson K., Harvima I.T., and Nilsson G. Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells J. Invest. Dermatol. 120 2003 239 245
128. 4 receptor mediates chemotaxis and calcium mobilization of mast cells J. Pharmacol. Exp. Ther. 305 2003 1212 1221
129. Holash J., Davis S., Papadopoulos N., Croll S.D., Ho L., Russell M., Boland P., Leidich R., Hylton D., Burova E., Ioffe E., Huang T., Radziejewski C., Bailey K., Fandl J.P., Daly T., Wiegand S.J., Yancopoulos G.D., and Rudge J.S. VEGF-Trap: A VEGF blocker with potent antitumor effects Proc. Natl. Acad. Sci. USA 99 2002 11393 11398
130. Holford-Strevens V., Warren P., Wong C., and Manfreda J. Serum total immunoglobulin E levels in Canadian adults J. Allergy Clin. Immunol. 73 1984 516 522
131. Holgate S.T., Lackie P., Wilson S., Roche W., and Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma Am. J. Respir. Crit. Care Med. 162 2000 S113 S117
132. Holgate S.T., Davies D.E., Rorke S., Cakebread J., Murphy G., Powell R.M., and Holloway J.W. Identification and possible functions of ADAM 33 as an asthma susceptibility gene G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 49 55
133. Holtzman M.J., Morton J.D., Shornick L.P., Tyner J.W., O'Sullivan M.P., Antao A., Lo M., Castro M., and Walter M.J. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm Physiol. Rev. 82 2002 19 46
134. Horton M.A., and O'Brien H.A. Characterization of human mast cells in long-term culture Blood 62 1983 1251 1260
135. Hoshino M., Nakamura Y., and Hamid Q.A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma J. Allergy Clin. Immunol. 107 2001 1034 1038
136. Hosoda M., Yamaya M., Suzuki T., Yamada N., Kamanaka M., Sekizawa K., Butterfield J.H., Watanabe T., Nishimura H., and Sasaki H. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils J. Immunol. 169 2002 1482 1491
137. 4 synthase expression by IL-4 J. Exp. Med. 193 2001 123 133
138. Huang E., Nocka K., Beier D.R., Chu T.Y., Buck J., Lahm H.W., Wellner D., Leder P., and Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus Cell 63 1990 225 233
139. 4 release J. Pharmacol. Exp. Ther. 284 1998 847 857
140. Ikeda K., Nakajima H., Suzuki K., Kagami S., Hirose K., Suto A., Saito Y., and Iwamoto I. Mast cells produce interleukin-25 upon FcεRI-mediated activation Blood 101 2003 3594 3596
141. 2 ε protein A interactions Scand. J. Immunol. 13 1981 343 352
142. Inganäs M., Johansson S.G., and Bennich H.H. Interaction of human polyclonal IgE and IgG from different species with protein A from Staphylococcus aureus: demonstration of protein-A-reactive sites located in the Fab'2 fragment of human IgG Scand. J. Immunol. 12 1980 23 31
143. Inman M.D., Watson R., Cockcroft D.W., Wong B.J., Hargreave F.E., and O'Byrne P.M. Reproducibility of allergen-induced early and late asthmatic responses J. Allergy Clin. Immunol. 95 1995 1191 1195
144. Irani A.M., Nilsson G., Miettinen U., Craig S.S., Ashman L.K., Ishizaka T., Zsebo K.M., and Schwartz L.B. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells Blood 80 1992 3009 3021
145. Irani A.A., Nilsson G., Ashman L.K., and Schwartz L.B. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor Immunology 84 1995 72 78
146. Irani A.M., Huang C., Xia H.Z., Kepley C., Nafie A., Fouda E.D., Craig S., Zweiman B., and Schwartz L.B. Immunohistochemical detection of human basophils in late-phase skin reactions J. Allergy Clin. Immunol. 101 1998 354 362
147. ISAAC Steering, Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC Lancet 351 1998 1225 1232
148. Ishizaka K., and Ishizaka T. Physicochemical properties of human reaginic antibody. I. Association of reaginic activity with an immunoglobulin other than A or G globulin J. Allergy 37 1966 169
149. Israel E., Cohn J., Dube L., and Drazen J.M. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group JAMA 275 1996 931 936
150. Israël-Biet D., Labrousse F., Tourani J.M., Sors H., Andrieu J.M., and Even P. Elevation of IgE in HIV-infected subjects: A marker of poor prognosis J. Allergy Clin. Immunol. 89 1992 68 75
151. Jeong H.J., Na H.J., Hong S.H., and Kim H.M. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone Endocrinology 144 2003 4080 4086
152. Jinnin M., Ihn H., Yamane K., and Tamaki K. Interleukin-13 stimulates the transcription of the human α2(I) collagen gene in human dermal fibroblasts J. Biol. Chem. 279 2004 41783 41791
153. Jogie-Brahim S., Min H.K., Fukuoka Y., Xia H.Z., and Schwartz L.B. Expression of α-tryptase and β-tryptase by human basophils J. Allergy Clin. Immunol. 113 2004 1086 1092
154. Johnston S.L. Bronchial hyperresponsiveness and cytokines in virus-induced asthma exacerbations Clin. Exp. Allergy 27 1997 7 9
155. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., and Holgate S.T. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children BMJ 310 1995 1225 1229
156. Kalesnikoff J., Huber M., Lam V., Damen J.E., Zhang J., Siraganian R.P., and Krystal G. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival Immunity 14 2001 801 811
157. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses J. Immunol. 173 2004 1503 1510
158. Kaplan M.H., Sadick N., McNutt N.S., Meltzer M., Sarngadharan M.G., and Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS) J. Am. Acad. Dermatol. 16 1987 485 506
159. Karray S., and Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120 Proc. Natl. Acad. Sci. USA 94 1997 1356 1360
160. Karray S., Juompan L., Maroun R.C., Isenberg D., Silverman G.J., and Zouali M. Structural basis of the gp120 superantigen-binding site on human immunoglobulins J. Immunol. 161 1998 6681 6688
161. Kastern W., Sjobring U., and Bjorck L. Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain J. Biol. Chem. 267 1992 12820 12825
162. 4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma J. Allergy Clin. Immunol. 109 2002 936 942
163. Kawanami O., Ferrans V.J., Fulmer J.D., and Crystal R.G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders Lab. Invest. 40 1979 717 734
164. Kepley C.L., Cambier J.C., Morel P.A., Lujan D., Ortega E., Wilson B.S., and Oliver J.M. Negative regulation of FcεRI signaling by FcγRII costimulation in human blood basophils J. Allergy Clin. Immunol. 106 2000 337 348
165. Kepley C.L., McFeeley P.J., Oliver J.M., and Lipscomb M.F. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma Am. J. Respir. Crit. Care Med. 164 2001 1053 1058
166. + bone marrow progenitor cells J. Immunol. 146 1991 1410 1415
167. + pluripotent progenitor cells J. Immunol. 148 1992 772 777
168. Kitamura Y., and Go S. Decreased production of mast cells in S1/S1d anemic mice Blood 53 1979 492 497
169. Kitamura Y., Go S., and Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation Blood 52 1978 447 452
170. KleinJan A., McEuen A.R., Dijkstra M.D., Buckley M.G., Walls A.F., and Fokkens W.J. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation J. Allergy Clin. Immunol. 106 2000 677 686
171. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., and Ishizaka K. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model J. Immunol. 164 2000 3855 3861
172. Koshino T., Teshima S., Fukushima N., Takaishi T., Hirai K., Miyamoto Y., Arai Y., Sano Y., Ito K., and Morita Y. Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma Clin. Exp. Allergy 23 1993 919 925
173. Koutsonikolis A., Nelson R.P. Jr., Fernandez-Caldas E., Brigino E.N., Seleznick M., Good R.A., and Lockey R.F. Serum total and specific IgE levels in children infected with human immunodeficiency virus J. Allergy Clin. Immunol. 97 1996 692 697
174. Kraneveld A.D., van der Kleij H.P., Kool M., van Houwelingen A.H., Weitenberg A.C., Redegeld F.A., and Nijkamp F.P. Key role for mast cells in nonatopic asthma J. Immunol. 169 2002 2044 2053
175. H2 cytokines on SCF-dependent human mast cell production in vitro: Correlation with apoptosis and Kit expression Blood 105 2005 592 599
176. Kulka M., Alexopoulou L., Flavell R.A., and Metcalfe D.D. Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3 J. Allergy Clin. Immunol. 114 2004 174 182
177. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., Elias J.A., Sheppard D., and Erle D.J. Direct effects of IL-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma Nat. Med. 8 2002 885 889
178. 4 and granulocytic infiltration into asthmatic airways Lancet 341 1993 989 990
179. Lam V., Kalesnikoff J., Lee C.W., Hernandez-Hansen V., Wilson B.S., Oliver J.M., and Krystal G. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor Blood 102 2003 1405 1413
180. Larché M., Robinson D.S., and Kay A.B. The role of T lymphocytes in the pathogenesis of asthma J. Allergy Clin. Immunol. 111 2003 450 463
181. Lavker R.M., and Schechter N.M. Cutaneous mast cell depletion results from topical corticosteroid usage J. Immunol. 135 1985 2368 2373
182. Lee J.H., Kaminski N., Dolganov G., Grunig G., Koth L., Solomon C., Erle D.J., and Sheppard D. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types Am. J. Respir. Cell Mol. Biol. 25 2001 474 485
183. Lee Y.C., and Lee H.K. Vascular endothelial growth factor in patients with acute asthma J. Allergy Clin. Immunol. 107 2001 1106
184. Leung D.Y., and Bloom J.W. Update on glucocorticoid action and resistance J. Allergy Clin. Immunol. 111 2003 3 22
185. Leung D.Y., Hauk P., Strickland I., Travers J.B., and Norris D.A. The role of superantigens in human diseases: Therapeutic implications for the treatment of skin diseases Br. J. Dermatol. 139 1998 17 29
186. Levi-Schaffer F., and Pe'er J. Mast cells and angiogenesis Clin. Exp. Allergy 31 2001 521 524
187. Levi-Schaffer F., and Rubinchik E. Activated mast cells are fibrogenic for 3T3 fibroblasts J. Invest. Dermatol. 104 1995 999 1003
188. 2, and leukotrienes J. Immunol. 139 1987 494 500
189. Levi-Schaffer F., Garbuzenko E., Rubin A., Reich R., Pickholz D., Gillery P., Emonard H., Nagler A., and Maquart F.A. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor β (TGF-β) Proc. Natl. Acad. Sci. USA 96 1999 9660 9665
190. Li H., Sim T.C., Grant J.A., and Alam R. The production of macrophage inflammatory protein-1α by human basophils J. Immunol. 157 1996 1207 1212
191. Li X., and Wilson J.W. Increased vascularity of the bronchial mucosa in mild asthma Am. J. Respir. Crit. Care Med. 156 1997 229 233
192. 2 receptor Nature 244 1973 287 288
193. 2 antihistamines on "allergic" histamine release and its inhibition by histamine J. Pharmacol. Exp. Ther. 192 1975 441 450
194. Lichtenstein L.M., and Margolis S. Histamine release in vitro: Inhibition by catecholamines and methylxanthines Science 161 1968 902 903
195. Liu M.C., Hubbard W.C., Proud D., Stealey B.A., Galli S.J., Kagey-Sobotka A., Bleecker E.R., and Lichtenstein L.M. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes Am. Rev. Respir. Dis. 144 1991 51 58
196. Lorentz A., Schuppan D., Gebert A., Manns M.P., and Bischoff S.C. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins Blood 99 2002 966 972
197. Lukacs N.W. Role of chemokines in the pathogenesis of asthma Nat. Rev. Immunol. 1 2001 108 116
198. Lukacs N.W., John A., Berlin A., Bullard D.C., Knibbs R., and Stoolman L.M. E- and P-selectins are essential for the development of cockroach allergen-induced airway responses J. Immunol. 169 2002 2120 2125
199. Lusková P., and Dráber P. Modulation of the FcεRI signaling by tyrosine kinase inhibitors: Search for therapeutic targets of inflammatory and allergy diseases Curr. Pharm. Des. 10 2004 1727 1737
200. 1 receptor Nature 399 1999 789 793
201. Macfarlane A.J., Kon O.M., Smith S.J., Zeibecoglou K., Khan L.N., Barata L.T., McEuen A.R., Buckley M.G., Walls A.F., Meng Q., Humbert M., Barnes N.C., Robinson D.S., Ying S., and Kay A.B. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin J. Allergy Clin. Immunol. 105 2000 99 107
202. MacGlashan D. Jr. Two regions of down-regulation in the IgE-mediated signaling pathway in human basophils J. Immunol. 170 2003 4914 4925
203. MacGlashan D.W. Jr., Lavens-Phillips S., and Miura K. Perspectives on the regulation of secretion from human basophils and mast cells G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 195 207
204. MacGlashan D.W. Jr., Miura K., and Lavens-Phillips S. Pharmacology of IgE-mediated desensitization of human basophils: Effects of protein kinase C and src-family kinase inhibitors Biochem. Pharmacol. 60 2000 1717 1727
205. MacGlashan D.W. Jr., White J.M., Huang S.K., Ono S.J., Schroeder J.T., and Lichtenstein L.M. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils J. Immunol. 152 1994 3006 3016
206. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α Nature 381 1996 77 80
207. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., and Abraham S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48 Proc. Natl. Acad. Sci. USA 96 1999 8110 8115
208. 4, increase the release of mucus from human airways in vitro Am. Rev. Respir. Dis. 126 1982 449 451
209. 1-receptor antagonists Allergy 52 1997 7 13
210. Marone G. Asthma: Recent advances Immunol. Today 19 1998 5 9
211. Marone G. Tacrolimus ointment for atopic dermatitis N. Engl. J. Med. 339 1998 1788
212. Marone G., Poto S., Petracca R., Triggiani M., de Lutio di Castelguidone E., and Condorelli M. Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments Clin. Exp. Immunol. 50 1982 661 668
213. Marone G., Ambrosio G., Bonaduce D., Genovese A., Triggiani M., and Condorelli M. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol Int. Arch. Allergy Appl. Immunol. 74 1984 356 361
214. Marone G., Tamburini M., Giudizi M.G., Biagiotti R., Almerigogna F., and Romagnani S. Mechanism of activation of human basophils by Staphylococcus aureus Cowan 1 Infect. Immun. 55 1987 803 809
215. Marone G., Granata F., Spadaro G., Onorati A.M., and Triggiani M. Antiinflammatory effects of oxatomide J. Invest. Allergol. Clin. Immunol. 9 1999 207 214
216. Marone G., Lichtenstein L.M., and Galli S.J. "Mast Cells and Basophils." 2000 Academic Press San Diego
217. + cells in HIV-1 infection Immunol. Rev. 179 2001 128 138
218. Marone G., Austen K.F., Holgate S.T., Kay A.B., and Lichtenstein L.M. "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment." 2004 Blackwell London
219. Marone G., Rossi F.W., Bova M., Detoraki B., Liccardo B., and Petraroli A. Superallergens: a novel mechanism of IgE-mediated activation of human basophils and mast cells G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 64 75
220. Marone G., Prevete N., De Rienzo G., Fiorentino I., Rossi F.W., Liccardo B., and de Paulis A. Role of mast cells and basophils in angiogenesis in respiratory allergies 2005 XVIII IFOS World Congress Rome
221. Marone G., Triggiani M., and de Paulis A. Mast cells and basophils: Friends as well as foes in bronchial asthma? Trends Immunol. 26 2005 25 31
222. Marshall J.S., and Jawdat D.M. Mast cells in innate immunity J. Allergy Clin. Immunol. 114 2004 21 27
223. Mashikian M.V., Tarpy R.E., Saukkonen J.J., Lim K.G., Fine G.D., Cruikshank W.W., and Center D.M. Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients J. Allergy Clin. Immunol. 101 1998 786 792
224. 2 as a mediator of allergic asthma Science 287 2000 2013 2017
225. Mayr S.I., Zuberi R.I., Zhang M., de Sousa-Hitzler J., Ngo K., Kuwabara Y., Yu L., Fung-Leung W.P., and Liu F.T. IgE-dependent mast cell activation potentiates airway responses in murine asthma models J. Immunol. 169 2002 2061 2068
226. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells J. Immunol. 170 2003 1625 1629
227. McEuen A.R., Calafat J., Compton S.J., Easom N.J., Buckley M.G., Knol E.F., and Walls A.F. Mass, charge, and subcellular localization of a unique secretory product identified by the basophil-specific antibody BB1 J. Allergy Clin. Immunol. 107 2001 842 848
228. Mekori Y.A., and Metcalfe D.D. Mast cell-T cell interactions J. Allergy Clin. Immunol. 104 1999 517 523
229. Mellor E.A., Maekawa A., Austen K.F., and Boyce J.A. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells Proc. Natl. Acad. Sci. USA 98 2001 7964 7969
230. Mellor E.A., Austen K.F., and Boyce J.A. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an IL-4-regulated pathway that is inhibited by leukotriene receptor antagonists J. Exp. Med. 195 2002 583 592
231. Miadonna A., Tedeschi A., Leggieri E., Invernizzi F., and Zanussi C. Basophil activation in idiopathic mixed cryoglobulinemia J. Clin. Immunol. 2 1982 309 313
232. Milgrom H., Fick R.B. Jr., Su J.Q., Reimann J.D., Bush R.K., Watrous M.L., and Metzger W.J. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group N. Engl. J. Med. 341 1999 1966 1973
233. Mitchell E.B., Crow J., Chapman M.D., Jouhal S.S., Pope F.M., and Platts-Mills T.A. Basophils in allergen-induced patch test sites in atopic dermatitis Lancet 1 1982 127 130
234. Mitsui H., Furitsu T., Dvorak A.M., Irani A.M., Schwartz L.B., Inagaki N., Takei M., Ishizaka K., Zsebo K.M., Gillis S., and Ishizaka T. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand Proc. Natl. Acad. Sci. USA 90 1993 735 739
235. Mochizuki A., Tamura N., Yatabe Y., Onodera S., Hiruma T., Inaba N., Kusunoki J., and Tomioka H. Suppressive effects of F-1322 on the antigen-induced late asthmatic response and pulmonary eosinophilia in guinea pigs Eur. J. Pharmacol. 430 2001 123 133
236. Mochizuki A., McEuen A.R., Buckley M.G., and Walls A.F. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: Validity of basogranulin measurement as an indicator of basophil activation J. Allergy Clin. Immunol. 112 2003 102 108
237. Möller A., Lippert U., Lessmann D., Kolde G., Hamann K., Welker P., Schadendorf D., Rosenbach T., Luger T., and Czarnetzki B.M. Human mast cells produce IL-8 J. Immunol. 151 1993 3261 3266
238. Mwamtemi H.H., Koike K., Kinoshita T., Ito S., Ishida S., Nakazawa Y., Kurokawa Y., Shinozaki K., Sakashita K., Takeuchi K., Shiohara M., Kamijo T., Yasui Y., Ishiguro A., Kawano Y., Kitano K., Miyazaki H., Kato T., Sakuma S., and Komiyama A. An increase in circulating mast cell colony-forming cells in asthma J. Immunol. 166 2001 4672 4677
239. (164/165) and PlGF: Roles in angiogenesis and arteriogenesis Trends Cardiovasc. Med. 13 2003 169 175
240. Nakayama T., Yao L., and Tosato G. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors J. Clin. Invest. 114 2004 1317 1325
241. Nials A.T., Ball D.I., Butchers P.R., Coleman R.A., Humbles A.A., Johnson M., and Vardey C.J. Formoterol on airway smooth muscle and human lung mast cells: A comparison with salbutamol and salmeterol Eur. J. Pharmacol. 251 1994 127 135
242. Nilson B.H., Solomon A., Björck L., and Akerstrom B. Protein L from Peptostreptococcus magnus binds to the κ light chain variable domain J. Biol. Chem. 267 1992 2234 2239
243. Nilsson G., Forsberg K., Bodger M.P., Ashman L.K., Zsebo K.M., Ishizaka T., Irani A.M., and Schwartz L.B. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells Immunology 79 1993 325 330
244. Nilsson G., Butterfield J.H., Nilsson K., and Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells J. Immunol. 153 1994 3717 3723
245. 2 production from mast cells Eur. J. Immunol. 31 2001 1066 1075
246. Niyonsaba F., Iwabuchi K., Someya A., Hirata M., Matsuda H., Ogawa H., and Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis Immunology 106 2002 20 26
247. Noguchi E., Shibasaki M., Kamioka M., Yokouchi Y., Yamakawa-Kobayashi K., Hamaguchi H., Matsui A., and Arinami T. New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes Clin. Exp. Allergy 32 2002 93 96
248. Nouri-Aria K.T., Irani A.M., Jacobson M.R., O'Brien F., Varga E.M., Till S.J., Durham S.R., and Schwartz L.B. Basophil recruitment and IL-4 production during human allergen-induced late asthma J. Allergy Clin. Immunol. 108 2001 205 211
249. 4 formation in human blood basophils Blood 86 1995 4039 4049
250. Ochensberger B., Daepp G.C., Rihs S., and Dahinden C.A. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation Blood 88 1996 3028 3037
251. Ochensberger B., Tassera L., Bifrare D., Rihs S., and Dahinden C.A. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists Eur. J. Immunol. 29 1999 11 22
252. Ochi H., Hirani W.M., Yuan Q., Friend D.S., Austen K.F., and Boyce J.A. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro J. Exp. Med. 190 1999 267 280
253. Ochi H., De Jesus N.H., Hsieh F.H., Austen K.F., and Boyce J.A. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production Proc. Natl. Acad. Sci. USA 97 2000 10509 10513
254. Ogawa K., Kaminuma O., Kikkawa H., Nakata A., Asahina M., Egan R.W., Akiyama K., and Mori A. Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness Clin. Exp. Allergy 32 2002 140 148
255. Oguma T., Palmer L.J., Birben E., Sonna L.A., Asano K., and Lilly C.M. Role of prostanoid DP receptor variants in susceptibility to asthma N. Engl. J. Med. 351 2004 1752 1763
256. Ohkawara Y., Yamauchi K., Tanno Y., Tamura G., Ohtani H., Nagura H., Ohkuda K., and Takishima T. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering Am. J. Respir. Cell Mol. Biol. 7 1992 385 392
257. Okayama Y., Kobayashi H., Ashman L.K., Dobashi K., Nakazawa T., Holgate S.T., Church M.K., and Mori M. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation Eur. J. Immunol. 28 1998 708 715
258. Okumura S., Kashiwakura J., Tomita H., Matsumoto K., Nakajima T., Saito H., and Okayama Y. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI Blood 102 2003 2547 2554
259. Onorato J., Esposito S., Scovena E., Morandi B., Morelli M., Pizzi M., Zisa G., Marchisio P., and Principi N. Eosinophil involvement and serum IgE level in HIV-1-infected children J. Allergy Clin. Immunol. 104 1999 245 247
260. Ordonez C.L., Khashayar R., Wong H.H., Ferrando R., Wu R., Hyde D.M., Hotchkiss J.A., Zhang Y., Novikov A., Dolganov G., and Fahy J.V. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression Am. J. Respir. Crit. Care Med. 163 2001 517 523
261. Paganelli R., Scala E., Mezzaroma I., Pinter E., D'Offizi G., Fanales-Belasio E., Rosso R.M., Ansotegui I.J., Pandolfi F., and Aiuti F. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS J. Allergy Clin. Immunol. 95 1995 995 1003
262. Page S., Ammit A.J., Black J.L., and Armour C.L. Human mast cell and airway smooth muscle cell interactions: Implications for asthma Am. J. Physiol. Lung Cell. Mol. Physiol. 281 2001 1313 1323
263. 2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line J. Immunol. 172 2004 4048 4058
264. Patella V., Casolaro V., Björck L., and Marone G. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells J. Immunol. 145 1990 3054 3061
265. Patella V., Bouvet J.P., and Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells J. Immunol. 151 1993 5685 5698
266. Patella V., Marinò I., Lamparter B., Arbustini E., Adt M., and Marone G. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization J. Immunol. 154 1995 2855 2865
267. Patella V., de Crescenzo G., Marinò O., Spadaro G., Genovese A., and Marone G. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells Int. Arch. Allergy Immunol. 111 1996 23 29
268. H3 region of IgE J. Immunol. 161 1998 5647 5655
269. Patella V., Marinò I., Arbustini E., Lamparter-Schummert B., Verga L., Adt M., and Marone G. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy Circulation 97 1998 971 978
270. Patella V., Florio G., Oriente A., Spadaro G., Forte V., Genovese A., and Marone G. Human mast cells and basophils in immune responses to infectious agents G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 397 418
271. H3 region of IgE J. Immunol. 164 2000 589 595
272. Pawankar R., Okuda M., Yssel H., Okumura K., and Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells J. Clin. Invest. 99 1997 1492 1499
273. Peachell P.T., Undem B.J., Schleimer R.P., Mac Glashan D.W. Jr., Lichtenstein L.M., Cieslinski L.B., and Torphy T.J. Preliminary identification and role of phosphodiesterase isozymes in human basophils J. Immunol. 148 1992 2503 2510
274. Pesci A., Foresi A., Bertorelli G., Chetta A., and Olivieri D. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects Am. Rev. Respir. Dis. 147 1993 684 689
275. 2 in modulating histamine release from human basophils J. Pharmacol. Exp. Ther. 228 1984 400 406
276. Popp J.W. Jr., Harrist T.J., Dienstag J.L., Bhan A.K., Wands J.R., La Mont J.T., and Mihm M.C. Jr. Cutaneous vasculitis associated with acute and chronic hepatitis Arch. Intern. Med. 141 1981 623 629
277. Presta L.G., Chen H., O'Connor S.J., Chisholm V., Meng Y.G., Krummen L., Winkler M., and Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders Cancer Res. 57 1997 4593 4599
278. Prewett M., Huber J., Li Y., Santiago A., O'Connor W., King K., Overholser J., Hooper A., Pytowski B., Witte L., Bohlen P., and Hicklin D.J. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors Cancer Res. 59 1999 5209 5218
279. Price K.S., Friend D.S., Mellor E.A., De Jesus N., Watts G.F., and Boyce J.A. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13 Am. J. Respir. Cell Mol. Biol. 28 2003 420 427
280. Prodeus A.P., Zhou X., Maurer M., Galli S.J., and Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice Nature 390 1997 172 175
281. Ramires R., Caiaffa M.F., Tursi A., Haeggstrom J.Z., and Macchia L. Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast Biochem. Biophys. Res. Commun. 324 2004 815 821
282. Rancinan C., Morlat P., Chene G., Guez S., Baquey A., Beylot J., and Salamon R. IgE serum level: A prognostic marker for AIDS in HIV-infected adults? J. Allergy Clin. Immunol. 102 1998 329 330
283. Redrup A.C., Howard B.P., Mac Glashan D.W. Jr., Kagey-Sobotka A., Lichtenstein L.M., and Schroeder J.T. Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures J. Immunol. 160 1998 1957 1964
284. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., Lucarelli G., and Dammacco F. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes Leukemia 16 2002 1680 1684
285. Ricci S., Medaglini D., Marcotte H., Olsen A., Pozzi G., and Bjorck L. Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii Microb. Pathog. 30 2001 229 235
286. Roche W.R., Beasley R., Williams J.H., and Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics Lancet 1 1989 520 524
287. Romagnani P., de Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., Romagnani S., and Marone G. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines Am. J. Pathol. 155 1999 1195 1204
288. Romagnani P., de Paulis A., Beltrame C., Marone G., and Romagnani S. Chemokine receptors on human mast cells G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 579 596
289. Romagnani P., Lasagni L., Annunziato F., Serio M., and Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis Trends Immunol. 25 2004 201 209
290. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: Missing immune deviation, reduced immune suppression, or both? Immunology 112 2004 352 363
291. Roquet A., Dahlen B., Kumlin M., Ihre E., Anstren G., Binks S., and Dahlen S.E. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics Am. J. Respir. Crit. Care Med. 155 1997 1856 1863
292. - cell population Blood 84 1994 2489 2496
293. + T lymphocyte chemoattractant factor, IL-16 J. Immunol. 159 1997 2904 2910
294. Ruoss S.J., Hartmann T., and Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts J. Clin. Invest. 88 1991 493 499
295. Russel J.D., Russell S.B., and Trupin K.M. The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue J. Cell. Physiol. 93 1977 389 393
296. Ruzicka T., Bieber T., Schopf E., Rubins A., Dobozy A., Bos J.D., Jablonska S., Ahmed I., Thestrup-Pedersen K., Daniel F., Finzi A., and Reitamo S. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group N. Engl. J. Med. 337 1997 816 821
297. Sadakane K., Ichinose T., Takano H., Yanagisawa R., Sagai M., Yoshikawa T., and Shibamoto T. Murine strain differences in airway inflammation induced by diesel exhaust particles and house dust mite allergen Int. Arch. Allergy Immunol. 128 2002 220 228
298. Saito H., Hatake K., Dvorak A.M., Leiferman K.M., Donnenberg A.D., Arai N., Ishizaka K., and Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins Proc. Natl. Acad. Sci. USA 85 1988 2288 2292
299. Sallusto F., Mackay C.R., and Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells Science 277 1997 2005 2007
300. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects Thorax 56 2001 902 906
301. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma Am. J. Respir. Cell Mol. Biol. 23 2000 290 296
302. Schechter N.M., Irani A.M., Sprows J.L., Abernethy J., Wintroub B., and Schwartz L.B. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell J. Immunol. 145 1990 2652 2661
303. Schechter N.M., Barbosa Pereira P.J., and Strobl S. Structure and function of human chymase G. Marone L.M. Lichtenstein S.J. Galli "Mast Cells and Basophils" 2000 Academic Press San Diego 275 290
304. Schleimer R.P., Lichtenstein L.M., and Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids Nature 292 1981 454 455
305. Schleimer R.P., Schulman E.S., Mac Glashan D.W. Jr., Peters S.P., Hayes E.C., Adams G.K. 3rd, Lichtenstein L.M., and Adkinson N.F. Jr. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells J. Clin. Invest. 71 1983 1830 1835
306. Schleimer R.P., Fox C.C., Naclerio R.M., Plaut M., Creticos P.S., Togias A.G., Warner J.A., Kagey-Sobotka A., and Lichtenstein L.M. Role of human basophils and mast cells in the pathogenesis of allergic diseases J. Allergy Clin. Immunol. 76 1985 369 374
307. Schroeder J.T., Mac Glashan D.W. Jr., Mac Donald S.M., Kagey-Sobotka A., and Lichtenstein L.M. Regulation of IgE-dependent IL-4 generation by human basophils treated with glucocorticoids J. Immunol. 158 1997 5448 5454
308. Schroeder J.T., Schleimer R.P., Lichtenstein L.M., and Kreutner W. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine Clin. Exp. Allergy 31 2001 1369 1377
309. -/- mice FASEB J. 16 2002 1313 1315
310. Segool R.A., Lejtenyi C., and Taussig L.M. Articular and cutaneous prodromal manifestations of viral hepatitis J. Pediatr. 87 1975 709 712
311. Sillaber C., Baghestanian M., Hofbauer R., Virgolini I., Bankl H.C., Fureder W., Agis H., Willheim M., Leimer M., Scheiner O., Binder B.R., Kiener H.P., Bevec D., Fritsch G., Majdic O., Kress H.G., Gadner H., Lechner K., and Valent P. Molecular and functional characterization of the urokinase receptor on human mast cells J. Biol. Chem. 272 1997 7824 7832
312. Sillaber C., Geissler K., Scherrer R., Kaltenbrunner R., Bettelheim P., Lechner K., and Valent P. Type β transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils Blood 80 1992 634 641
313. Silverman G.J. B-cell superantigens Immunol. Today 18 1997 379 386
314. Silverman G.J. B-cell superantigens: Possible roles in immunodeficiency and autoimmunity Semin. Immunol. 10 1998 43 55
315. Sin A.Z., Roche E.M., Togias A., Lichtenstein L.M., and Schroeder J.T. Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects J. Allergy Clin. Immunol. 108 2001 387 393
316. Siraganian R.P. Mast cell signal transduction from the high-affinity IgE receptor Curr. Opin. Immunol. 15 2003 639 646
317. Sloane D.E., Tedla N., Awoniyi M., Mac Glashan D.W. Jr., Borges L., Austen K.F., and Arm J.P. Leukocyte immunoglobulin-like receptors: Novel innate receptors for human basophil activation and inhibition Blood 104 2004 2832 2839
318. Smith S.J., Piliponsky A.M., Rosenhead F., Elchalal U., Nagler A., and Levi-Schaffer F. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood-derived mast cells Clin. Exp. Allergy 32 2002 906 913
319. 4) in human skin J. Invest. Dermatol. 80 1983 115 119
320. Standaert R.F., Galat A., Verdine G.L., and Schreiber S.L. Molecular cloning and overexpression of the human FK506-binding protein FKBP Nature 346 1990 671 674
321. Stellato C., de Paulis A., Ciccarelli A., Cirillo R., Patella V., Casolaro V., and Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells J. Invest. Dermatol. 98 1992 800 804
322. Stellato C., Collins P., Ponath P.D., Soler D., Newman W., La Rosa G., Li H., White J., Schwiebert L.M., Bickel C., Liu M., Bochner B.S., Williams T., and Schleimer R.P. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines J. Clin. Invest. 99 1997 926 936
323. Stevens R.L., Yang Y., and Li L. RasGRP4 is a lineage-restricted, guanine nucleotide exchange factor/phorbol ester receptor that controls mast cell development G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 102 110
324. Suh Y.J., Yoon S.H., Sampson A.P., Kim H.J., Kim S.H., Nahm D.H., Suh C.H., and Park H.S. Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma Clin. Exp. Allergy 34 2004 1270 1275
325. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., and Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4 J. Immunol. 167 2001 2250 2256
326. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., and Ogawa H. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity J. Clin. Invest. 109 2002 1351 1359
327. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., and Gelfand E.W. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice J. Exp. Med. 186 1997 449 454
328. Takeuchi K., Koike K., Kamijo T., Ishida S., Nakazawa Y., Kurokawa Y., Sakashita K., Kinoshita T., Matsuzawa S., Shiohara M., Yamashita T., Nakajima M., and Komiyama A. STI571 inhibits growth and adhesion of human mast cells in culture J. Leukoc. Biol. 74 2003 1026 1034
329. Tanaka S., Takasu Y., Mikura S., Satoh N., and Ichikawa A. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells J. Exp. Med. 196 2002 229 235
330. Tkaczyk C., Okayama Y., Metcalfe D.D., and Gilfillan A.M. Fcγ receptors on mast cells: Activatory and inhibitory regulation of mediator release Int. Arch. Allergy Immunol. 133 2004 305 315
331. Torphy T.J., Livi G.P., Balcarek J.M., White J.R., Chilton F.H., and Undem B.J. Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma Adv. Second Messenger Phosphoprotein Res. 25 1992 289 305
332. Townsley-Fuchs J., Neshat M.S., Margolin D.H., Braun J., and Goodglick L. HIV-1 gp120: A novel viral B cell superantigen Int. Rev. Immunol. 14 1997 325 338
333. Trautmann A., Krohne G., Brocker E.B., and Klein C.E. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4 J. Immunol. 160 1998 5053 5057
334. Triggiani M., Hubbard W.C., and Chilton F.H. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell J. Immunol. 144 1990 4773 4780
335. Triggiani M., Schleimer R.P., Warner J.A., and Chilton F.H. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells J. Immunol. 147 1991 660 666
336. Triggiani M., Oriente A., de Crescenzo G., and Marone G. Metabolism of lipid mediators in human basophils and mast cells Chem. Immunol. 61 1995 135 147
337. Triggiani M., Oriente A., de Crescenzo G., Rossi G., and Marone G. Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells Int. Arch. Allergy Immunol. 107 1995 261 263
338. 1 receptors J. Immunol. 166 2001 4083 4091
339. Triggiani M., Giannattasio G., Balestrieri B., Granata F., Gelb M.H., de Paulis A., and Marone G. Differential modulation of mediator release from human basophils and mast cells by mizolastine Clin. Exp. Allergy 34 2004 241 249
340. Triggiani M., Giannattasio G., Balestrieri B., Loffredo S., Forte V., and Granata F. Phenotypical and functional heterogeneity of human lung macrophages G. Marone K.F. Austen S.T. Holgate A.B. Kay L.M. Lichtenstein "Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment" 2004 Blackwell London 129 134
341. Tsai M., Shih L.S., Newlands G.F., Takeishi T., Langley K.E., Zsebo K.M., Miller H.R., Geissler E.N., and Galli S.J. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype J. Exp. Med. 174 1991 125 131
342. Uguccioni M., Mackay C.R., Ochensberger B., Loetscher P., Rhis S., La Rosa G.J., Rao P., Ponath P.D., Baggiolini M., and Dahinden C.A. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines J. Clin. Invest. 100 1997 1137 1143
343. Upton M.N., McConnachie A., McSharry C., Hart C.L., Smith G.D., Gillis C.R., and Watt G.C. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: The Midspan family study surveys of parents and offspring BMJ 321 2000 88 92
344. Vaida G.A., Goldman M.A., and Bloch K.J. Testing for hepatitis B virus in patients with chronic urticaria and angioedema J. Allergy Clin. Immunol. 72 1983 193 198
345. Valent P., Schmidt G., Besemer J., Mayer P., Zenke G., Liehl E., Hinterberger W., Lechner K., Maurer D., and Bettelheim P. Interleukin-3 is a differentiation factor for human basophils Blood 73 1989 1763 1769
346. Valent P., Besemer J., Kishi K., Kaltenbrunner R., Kuhn B., Maurer D., Lechner K., and Bettelheim P. IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites J. Immunol. 145 1990 1885 1889
347. Valent P., Spanblöchl E., Sperr W.R., Sillaber C., Zsebo K.M., Agis H., Strobl H., Geissler K., Bettelheim P., and Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture Blood 80 1992 2237 2245
348. Van Epps E., Husby G., Williams R.C. Jr., and Strickland R.G. Liver disease - a prominent cause of serum IgE elevation Clin. Exp. Immunol. 23 1976 444 450
349. 4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States J. Allergy Clin. Immunol. 106 2000 72 76
350. Viganò A., Principi N., Crupi L., Onorato J., Vincenzo Z.G., and Salvaggio A. Elevation of IgE in HIV-infected children and its correlation with the progression of disease J. Allergy Clin. Immunol. 95 1995 627 632
351. Wide L., Bennich H., and Johansson S.G. Diagnosis of allergy by an in vitro test for allergen antibodies Lancet 2 1967 1105 1107
352. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice J. Exp. Med. 192 2000 455 462
353. Williams H.C. Is the prevalence of atopic dermatitis increasing? Clin. Exp. Dermatol. 17 1992 385 391
354. Wills-Karp M., and Ewart S.L. Time to draw breath: Asthma-susceptibility genes are identified Nat. Rev. Genet. 5 2004 376 387
355. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., and Donaldson D.D. Interleukin-13: Central mediator of allergic asthma Science 282 1998 2258 2261
356. Wood J.M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., Hofmann F., Mestan J., Mett H., O'Reilly T., Persohn E., Rosel J., Schnell C., Stover D., Theuer A., Towbin H., Wenger F., Woods-Cook K., Menrad A., Siemeister G., Schirner M., Thierauch K.H., Schneider M.R., Drevs J., Martiny-Baron G., and Totzke F. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res. 60 2000 2178 2189
357. Wright D.N., Nelson R.P. Jr., Ledford D.K., Fernandez-Caldas E., Trudeau W.L., and Lockey R.F. Serum IgE and human immunodeficiency virus (HIV) infection J. Allergy Clin. Immunol. 85 1990 445 452
358. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signaling - which way to target? Trends Pharmacol. Sci. 24 2003 366 376
359. Yano K., Yamaguchi M., de Mora F., Lantz C.S., Butterfield J.H., Costa J.J., and Galli S.J. Production of macrophage inflammatory protein-1α by human mast cells: Increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability Lab. Invest. 77 1997 185 193
360. Ying S., Robinson D.S., Meng Q., Barata L.T., McEuen A.R., Buckley M.G., Walls A.F., Askenase P.W., and Kay A.B. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES) J. Immunol. 163 1999 3976 3984
361. Yoshimoto T., Tsutsui H., Tominaga K., Hoshino K., Okamura H., Akira S., Paul W.E., and Nakanishi K. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils Proc. Natl. Acad. Sci. USA 96 1999 13962 13966
362. Yu C.K., and Chen C.L. Activation of mast cells is essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation in mice J. Immunol. 171 2003 3808 3815
363. Yuyama N., Davies D.E., Akaiwa M., Matsui K., Hamasaki Y., Suminami Y., Yoshida N.L., Maeda M., Pandit A., Lordan J.L., Kamogawa Y., Arima K., Nagumo F., Sugimachi M., Berger A., Richards I., Roberds S.L., Yamashita T., Kishi F., Kato H., Arai K., Ohshima K., Tadano J., Hamasaki N., Miyatake S., Sugita Y., Holgate S.T., and Izuhara K. Analysis of novel disease-related genes in bronchial asthma Cytokine 19 2002 287 296
364. Zhang S., Anderson D.F., Bradding P., Coward W.R., Baddeley S.M., Mac Leod J.D., McGill J.I., Church M.K., Holgate S.T., and Roche W.R. Human mast cells express stem cell factor J. Pathol. 186 1998 59 66
365. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., and Elias J.A. Pulmonary expression of IL-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production J. Clin. Invest. 103 1999 779 788